Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -107.86M
March 31, 2026 -39.44M
December 31, 2025 -55.75M
September 30, 2025 -59.31M
June 30, 2025 -41.06M
March 31, 2025 -37.28M
December 31, 2024 -63.05M
September 30, 2024 -126.77M
June 30, 2024 -33.91M
March 31, 2024 -39.36M
December 31, 2023 -120.61M
September 30, 2023 -35.70M
June 30, 2023 -41.10M
March 31, 2023 -28.04M
December 31, 2022 -59.62M
September 30, 2022 -34.57M
June 30, 2022 -27.85M
March 31, 2022 -19.54M
December 31, 2021 43.56M
September 30, 2021 -5.843B
June 30, 2021 -16.58M
March 31, 2021 -9.303M
December 31, 2020 -70.62M
September 30, 2020 -12.30M
June 30, 2020 -10.97M
Date Value
March 31, 2020 -0.758M
December 31, 2019 -29.39M
September 30, 2019 -36.58M
June 30, 2019 -43.74M
March 31, 2019 -50.56M
December 31, 2018 -19.45M
September 30, 2018 7.763M
June 30, 2018 -10.53M
March 31, 2018 -13.86M
December 31, 2017 -12.65M
September 30, 2017 -139.26M
June 30, 2017 -12.10M
March 31, 2017 -21.60M
December 31, 2016 6.192M
September 30, 2016 -62.04M
June 30, 2016 -9.436M
March 31, 2016 -7.598M
December 31, 2015 -78.62M
September 30, 2015 -8.814M
June 30, 2015 -1.83M
March 31, 2015 -112.85M
December 31, 2014 -9.031M
September 30, 2014 -10.79M
June 30, 2014 -91.33M
March 31, 2014 5.379M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. -381.00M
Medpace Holdings, Inc. -23.88M
Proteome Sciences Plc --
Champions Oncology, Inc. -0.055M
Avantor, Inc. -37.30M